KNSA
Kiniksa Pharmaceuticals International Plc
NASDAQ · Healthcare · Biotechnology · BM
$79.48
+1.13%Forward multiples
Based on analyst estimates
- P/E forward
- 45.39x
- P/E 2026E
- 58.26x
- P/E 2027E
- 39.33x
- P/E 2028E
- 29.12x
- P/S forward
- 5.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 74.28x
- PEG TTM
- 1.17x
- Price / book
- 9.48x
- Price / sales
- 7.38x
- Price / cash flow
- 33.48x
Enterprise value
- Enterprise value
- $5.7B
- EV / sales
- 6.76x
- EV / EBITDA
- 50.71x
- EV / EBIT
- 56.70x
- Market cap
- $6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026